Oscient Pharmaceuticals Corp. (OSCI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tara Cobble who wrote (53)	8/23/1996 12:37:00 AM
From: John B. Anderson	of 1154

Tara/All: Thanks for your information. Is the stock analyst at Oppenheimer who follows the stock Matt Geller? If so, I do know Matt and will check GENE out with him. As for Merrill Lynch, it is not unusual for a brokerage company to lose coverage of a company even if they brought them public. I have witnessed a couple of cases at Paine Webber, for instance. If the analyst leaves, so does their coverage.... Was GENE called Collaborative Research in '82? If so, the company has evolved substantially since that time! Thanks for your help! John_B_Anderson@prodigy.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next